Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the treatment of high-risk newly diagnosed multiple myeloma - Leypoldt, Lisa; Tichy, Diana; Besemer, Britta; Hänel, Mathias; Raab, Marc-Steffen; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; et al. (Journal of clinical oncology, 2024)
Veröffentlicht: 27. September 2023